Article Details
Retrieved on: 2017-12-07 08:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>DePristo left to pursue a <b>Google Ventures</b>-backed start-up called SynapDx that was developing a blood test for autism. When that folded two years later, one of its board members, Andrew Conrad (of Google X, then Google Life Sciences, then Verily) convinced DePristo to join the Google/Alphabet fold.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here